Total investments 24
Average round size 
$56M
The average size of a deal this fund participated in
Portfolio companies 19
Rounds per year 2.18
Lead investments 5
Follow on index
0.21How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees Soon
New York, New York, United States Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Delos Capital:
Typical Co-investors
Delos Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Delos Capital:
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Bain Capital Private Equity | England, London, United Kingdom |
| Brandshoots Ventures | India, Kolkata, West Bengal |
| Capital One Growth Ventures | California, San Francisco, United States |
| DiGAME | Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates |
| Fidelity National Title Insurance | California, Santa Rosa, United States |
| Gfund | Beijing, Beijing, China |
| Global Investment House | Al Kuwayt, Kuwait, Safat |
| ICT Group N.V. | Barendrecht, The Netherlands, Zuid-Holland |
| Innovus | South Africa, Stellenbosch, Western Cape |
| Jollibee Food | Pasig, Philippines, Rizal |
| MetLife Digital Accelerator powered by Techstars | Cary, North Carolina, United States |
| NetSol Technologies | Calabasas, California, United States |
| Parrot | France, Ile-de-France, Paris |
| Shanghai Momoying Investment Development Center (LP) | - |
| Solent Local Enterprise Partnership | Hampshire, Portsmouth, United Kingdom |
| Southern Oregon Angel Investors Network | Medford, Oregon, United States |
| The Vinik Family Foundation | - |
| Zhiying Capital | China, Shanghai |
| Zuma Ventures | California, Santa Monica, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Avenzo Therapeutics | $150M | 26 Mar 2024 | San Diego, California, United States | ||
Instylla | $30M | 15 Aug 2023 | Massachusetts, United States | ||
Eccogene | $27M | 12 Jun 2023 | Shanghai, China | ||
Ensoma | $50M | 16 May 2023 | Boston, Massachusetts, United States | ||
Rejoni | $25M | 07 Dec 2022 | Bedford, Massachusetts, United States | ||
Rgenta Therapeutics | $52M | 29 Nov 2022 | Cambridge, Massachusetts, United States | ||
OncoMyx Therapeutics | $50M | 09 Dec 2021 | Phoenix, Arizona, United States | ||
OncoMyx Therapeutics | $50M | 08 Dec 2021 | Tempe, Arizona, United States | ||
| $40M | 07 May 2021 | San Diego, California, United States |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Delos Capital?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 24
Average round size 56M
Rounds per year 2.18
Peak activity year 2021
Lead investments 5
Follow on index 0.21
Exits 2
Group Appearance index 0.92
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Avenzo Therapeutics | $150M | 26 Mar 2024 | San Diego, California, United States | ||
Instylla | $30M | 15 Aug 2023 | Massachusetts, United States | ||
Eccogene | $27M | 12 Jun 2023 | Shanghai, China | ||
Ensoma | $50M | 16 May 2023 | Boston, Massachusetts, United States | ||
Rejoni | $25M | 07 Dec 2022 | Bedford, Massachusetts, United States | ||
Rgenta Therapeutics | $52M | 29 Nov 2022 | Cambridge, Massachusetts, United States | ||
OncoMyx Therapeutics | $50M | 09 Dec 2021 | Phoenix, Arizona, United States | ||
OncoMyx Therapeutics | $50M | 08 Dec 2021 | Tempe, Arizona, United States | ||
| $40M | 07 May 2021 | San Diego, California, United States |
